Papers/PMID:28604618
Trans-Resveratrol Supplementation and Endothelial Function during the Fasting and Postprandial Phase: A Randomized Placebo-Controlled Trial in Overweight and Slightly Obese Participants.
Nutrients2017The record
2 findings · 1 compound · 2 endpoints · 2 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
2 findings
resveratrol — no detected effect on triglycerides
LimitedEvidence strength: limited. Human evidence with several recorded weaknesses, or a design that tops out at limited.FindingNull resultreplicated ×2“Fasting concentrations of plasma glucose, plasma insulin, and serum triacylglycerol did not differ between the test days at the end of the placebo and trans-resveratrol periods.”
Quoted verbatim from Trans-Resveratrol Supplementation and Endothelial Function during the Fasting and Postprandial Phase: A Randomized Placebo-Controlled Trial in Overweight and Slightly Obese Participants.. - Study
- crossover
- Duration
- 4 weeks
- Dose
- trans-resveratrol 2 x 75 mg/day vs placebo (cellulose)
- Population
- Overweight and slightly obese healthy adults aged 45-70 years; fasting samples after a 12 h overnight fast at the end of each 4-week period
Trans-Resveratrol Supplementation and Endothelial Function during the Fasting and Postprandial Phase: A Randomized Placebo-Controlled Trial in Overweight and Slightly Obese Participants.2017PMID:28604618Industry fundedPermalink
resveratrol — no detected effect on flow-mediated dilation
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Fasting FMD values at the end of the placebo and trans-resveratrol periods were not significantly different.”
Quoted verbatim from Trans-Resveratrol Supplementation and Endothelial Function during the Fasting and Postprandial Phase: A Randomized Placebo-Controlled Trial in Overweight and Slightly Obese Participants.. - Study
- crossover
- Duration
- 4 weeks
- Dose
- trans-resveratrol 2 x 75 mg/day vs placebo (cellulose)
- Population
- Overweight and slightly obese healthy adults aged 45-70 years; fasting measurement at the end of each 4-week period
Trans-Resveratrol Supplementation and Endothelial Function during the Fasting and Postprandial Phase: A Randomized Placebo-Controlled Trial in Overweight and Slightly Obese Participants.2017PMID:28604618Industry fundedPermalink